Statistics on Biotechnology Use Business Sector Biotechnology indicators by company size. Unidades: Specified in each variable Less than 250 employees 250 and more employees Total Number of companies carrying out R&D in Biotechnology 1.284 160 1.444 % Companies by type of biotechnology used: Genetic Code 29,7 38,6 30,7 % Companies by type of biotechnology used: Functional Units 36,6 45,5 37,6 % Companies by type of biotechnology used: Cell and Tissue Culture and Engineering 20 31,6 21,3 % Companies by type of biotechnology used: Bioprocesses 49,5 62,6 50,9 % Companies by type of biotechnology used: Subcellular Organisms 6,8 18,3 8,1 % Companies by type of biotechnology used: Bioinformatics 22,1 26,6 22,6 % Companies by type of biotechnology used: Nanobiotechnology 9,8 10,2 9,8 % Companies by type of biotechnology used: Other 16,8 17,2 16,9 Companies in which biotechnology activities are: Main and/or exclusive 604 25 629 Companies in which biotechnology activities are: A secondary business line 215 47 262 Companies in which biotechnology activities are: A necessary tool for production 465 88 553 % Companies by final application areas of biotechnology use: Human Health 44,7 41,1 44,3 % Companies by final application areas of biotechnology use: Animal Health and Aquaculture 16,2 12,1 15,8 % Companies by final application areas of biotechnology use: Food Products 29,4 41,1 30,7 % Companies by final application areas of biotechnology use: Agriculture and Forestry 25,6 20,1 24,9 % Companies by final application areas of biotechnology use: Environment 17,3 13,9 16,9 % Companies by final application areas of biotechnology use: Industry 12,5 13,3 12,6 R&D personnel in Biotechnology (PP) 10.452 7.291 17.743 R&D personnel in Biotechnology (PP): Research personnel 6.309 3.136 9.445 R&D personnel in Biotechnology (PP): Technical and auxiliary personnel 4.144 4.154 8.298 R&D personnel in Biotechnology (PP). Women 5.369 4.538 9.907 R&D personnel in Biotechnology (PP). Women: Research personnel 3.273 1.832 5.104 R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel 2.096 2.707 4.802 R&D personnel in Biotechnology (FTE) 7.232,7 5.760,8 12.993,4 R&D personnel in Biotechnology (FTE): Research personnel 4.671,5 2.398,3 7.069,9 R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel 2.561,2 3.362,4 5.923,6 R&D personnel in Biotechnology (FTE). Women 3.763,9 3.707,8 7.471,8 R&D personnel in Biotechnology (FTE). Women: Research personnel 2.449,2 1.421 3.870,1 R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel 1.314,8 2.286,9 3.601,6 Expenditure on internal R&D in Biotechnology (thousands of euros) 691.268 532.533 1.223.801 1) By type of expenditure: Current expenditure 614.656 493.534 1.108.189 1.1) Labour expenditure of research personnel 221.957 138.965 360.922 1.2) Labour expenditure of technical and auxiliary personnel 96.161 124.379 220.540 1.3) Other current expenditure 296.538 230.190 526.727 2) By type of expenditure: Capital expenditure 76.612 39.000 115.612 2.1) Land and buildings 7.247 9.596 16.843 2.2) Equipment and tools 37.708 25.819 63.527 2.3) Acquisition of specific R&D software 2.767 1.191 3.959 2.4) Other R&D-specific IP products 28.890 2.394 31.284 1.1) By origin of funds: Own funds 471.465 389.138 860.603 1.2) By origin of funds: Funds from the Business sector 77.630 50.371 128.002 1.3) By origin of funds: Funds from the Public Administration sector 96.976 22.523 119.498 1.4) By origin of funds: Funds from the Higher Education sector 647 0 647 1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector 1.563 11.423 12.986 1.6) By origin of funds: Funds from the rest of the world 42.988 59.078 102.065 Purchase of R&D services (external R&D) in Biotechnology (thousands of euros) 43.120 80.276 123.396 Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain 22.993 65.992 88.985 Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world 20.127 14.284 34.412 % Companies that consider the following obstacles to the development of biotechnologies as very important: Access to capital 41,8 23,6 39,8 % Companies that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information 15,2 16,4 15,3 % Companies that consider the following obstacles to the development of biotechnologies as very important: Access to human resources 22,9 17,3 22,3 % Companies that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain 11,5 17 12,1 % Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets 17,2 15,8 17,1 % Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels 18,1 15,3 17,8 % Companies that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception 15,4 20,3 16 % Companies that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements 41,8 38,5 41,4 % Companies that consider the following obstacles to the development of biotechnologies as very important: Time/cost 51 44,2 50,2 % Companies that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting 20,7 15,1 20,1 % Companies with international revenues related to biotechnology activities 23 20,2 22,7 % Companies representing international revenues related to biotechnology activities 8,2 1,3 2,1 % International revenues related to biotechnology activities distributed in: Revenues from the EU 55,4 64,9 60,6 % International revenues related to biotechnology activities distributed in: Revenues from the rest of the world 44,6 35,1 39,4 % International revenues related to biotechnology activities by classification: International trade in goods and services 93,9 82,8 87,8 % International revenues related to biotechnology activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain 3,8 15,1 10,1 % International revenues related to biotechnology activities by classification: Subsidies from external sources 0,7 2 1,4 % International revenues related to biotechnology activities by classification: Other 1,7 0 0,8 Notas: Data referring to all companies that carry out internal R&D in Biotechnology. 2) ' .'= numeric data equal to zero not resulting from rounding 3) FTE: Full-Time Equivalence Fuente: National Statistics Institute